|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.00 SEK | -0.32% |
|
-3.68% | -1.87% |
| 06-12 | Handelsbanken Fonder increases stake in Alligo to just over 5 percent | FW |
| 06-08 | Espiria Sweden Small Cap rose 6.1 percent in May - Hansa Biopharma contributed positively | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 429M | 4.06B | 491M | 274M | 261M | |||||
Depreciation & Amortization - CF | 512M | 387M | 439M | 511M | 501M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 104M | 99M | 94M | 97M | 107M | |||||
Depreciation & Amortization, Total | 616M | 486M | 533M | 608M | 608M | |||||
Amortization of Deferred Charges, Total - (CF) | 1M | - | - | - | - | |||||
(Gain) Loss From Sale Of Asset | 7M | - | 1M | - | 1M | |||||
Asset Writedown & Restructuring Costs | - | - | - | - | 6M | |||||
(Income) Loss On Equity Investments - (CF) | - | - | - | - | - | |||||
Net Cash From Discontinued Operations | 176M | -59M | - | - | - | |||||
Other Operating Activities, Total | -108M | -3.5B | -5M | -55M | 47M | |||||
Change In Accounts Receivable | -279M | -100M | 176M | 80M | -55M | |||||
Change In Inventories | -282M | -349M | -83M | 6M | -4M | |||||
Change in Other Net Operating Assets | 383M | -91M | -120M | 39M | -66M | |||||
Cash from Operations | 943M | 448M | 993M | 952M | 798M | |||||
Capital Expenditure | -114M | -108M | -172M | -93M | -93M | |||||
Sale of Property, Plant, and Equipment | 2M | 4M | 1M | 8M | 2M | |||||
Cash Acquisitions | -31M | -144M | -126M | -425M | -296M | |||||
Divestitures | -23M | - | - | -5M | - | |||||
Sale (Purchase) of Intangible assets | -44M | -38M | -39M | -22M | -21M | |||||
Investment in Marketable and Equity Securities, Total | -15M | -10M | -5M | -4M | 9M | |||||
Other Investing Activities, Total | -120M | - | - | - | - | |||||
Cash from Investing | -345M | -296M | -341M | -541M | -399M | |||||
Long-Term Debt Issued, Total | - | 1.87B | 92M | 460M | 107M | |||||
Total Debt Issued | - | 1.87B | 92M | 460M | 107M | |||||
Long-Term Debt Repaid, Total | -527M | -2.06B | -378M | -405M | -582M | |||||
Total Debt Repaid | -527M | -2.06B | -378M | -405M | -582M | |||||
Issuance of Common Stock | 9M | - | - | 2M | 2M | |||||
Repurchase of Common Stock | - | - | -46M | - | - | |||||
Common Dividends Paid | -76M | -88M | -151M | -175M | -100M | |||||
Common & Preferred Stock Dividends Paid | -76M | -88M | -151M | -175M | -100M | |||||
Other Financing Activities, Total | -35M | -6M | - | 1M | - | |||||
Cash from Financing | -629M | -281M | -483M | -117M | -573M | |||||
Foreign Exchange Rate Adjustments | 1M | -1M | -2M | -6M | -10M | |||||
Net Change in Cash | -30M | -130M | 167M | 288M | -184M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 44M | 58M | 124M | 157M | 143M | |||||
Cash Income Tax Paid (Refund) | 144M | 50M | 141M | 131M | 78M | |||||
Levered Free Cash Flow | 158M | 636M | 672M | 719M | 559M | |||||
Unlevered Free Cash Flow | 182M | 672M | 749M | 816M | 647M | |||||
Change In Net Working Capital | 539M | 86M | 41M | -5M | 146M | |||||
Net Debt Issued / Repaid | -527M | -187M | -286M | 55M | -475M |
Select your edition
All financial news and data tailored to specific country editions
















